Health and Fitness Health and Fitness
Wed, October 31, 2012
[ Wed, Oct 31st 2012 ] - Market Wire
American Board of Radiology Foundation receives g .. dical Systems for national brachytherapy registry
[ Wed, Oct 31st 2012 ] - Market Wire
Genomic Health to Announce Third Quarter 2012 Fin .. st Conference Call on Wednesday, November 7, 2012
[ Wed, Oct 31st 2012 ] - Market Wire
Kennedy Health System Renews System-Wide Pulse Oximetry Contract with Masimo
[ Wed, Oct 31st 2012 ] - Market Wire
NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results
[ Wed, Oct 31st 2012 ] - Market Wire
Hansen Medical Announces Expanded Agreement With Intuitive Surgical
[ Wed, Oct 31st 2012 ] - Market Wire
Lexicon to Provide Third Quarter 2012 Financial Results
Tue, October 30, 2012
[ Tue, Oct 30th 2012 ] - Market Wire
OncoGenex to Webcast Discussion of Third Quarter .. 2 Financial Results on Thursday, November 8, 2012
[ Tue, Oct 30th 2012 ] - Market Wire
Sarepta Therapeutics Announces Third Quarter 2012 .. cial Results and Corporate Update Conference Call
[ Tue, Oct 30th 2012 ] - Market Wire
Arrhythmia Research Technologies, Inc. Appoints Michael Gunter as Interim CEO
[ Tue, Oct 30th 2012 ] - Market Wire
Johnson amp;; Johnson Postpones Medical Devices amp;; Diagnostics Review
[ Tue, Oct 30th 2012 ] - Market Wire
Medicure Reports First Quarter Financial Results for Fiscal 2013
[ Tue, Oct 30th 2012 ] - Market Wire
Lilly Names Melissa Barnes Chief Ethics and Compl .. e President;; Announces Retirement of Anne
[ Tue, Oct 30th 2012 ] - Market Wire
Calyx's Operating Subsidiary Makes Aviation History, Powers the World's First 100% Biofuel Flight
[ Tue, Oct 30th 2012 ] - Market Wire
Revenue Growth and Expenditure Control at the Core of Revised Business Plan
[ Tue, Oct 30th 2012 ] - Market Wire
European Commission approves Cialis (tadalafil) t .. he signs and symptoms of benign prostatic hyperpl
[ Tue, Oct 30th 2012 ] - Market Wire
Horizon Pharma to Host Conference Call and Webcas .. arter 2012 Financial Results on November 13, 2012
Mon, October 29, 2012
[ Mon, Oct 29th 2012 ] - Market Wire
Masimo Reschedules Release of Third Quarter 2012 .. ted Conference Call to Thursday, November 1st Due
[ Mon, Oct 29th 2012 ] - Market Wire
SecureAlert Announces New Executive Management
[ Mon, Oct 29th 2012 ] - Market Wire
MSA Engineer Named Rising Star of Safety by the National Safety Council
[ Mon, Oct 29th 2012 ] - Market Wire
Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results
[ Mon, Oct 29th 2012 ] - Market Wire
BIOLASE to Discuss Third Quarter 2012 Financial Results on November 5, 2012 Conference Call
[ Mon, Oct 29th 2012 ] - Market Wire
Analyst Opinion on Eli Lilly &;; Co. an .. turers Countering Patent Expirations with New Pro
[ Mon, Oct 29th 2012 ] - Market Wire
Financial Review on Healthcare Stocks DaVita Inc. .. pecialized Health Industry Faces Growth Obstacles
[ Mon, Oct 29th 2012 ] - Market Wire
Watson Announces Sale of Rugby OTC Product Tradem .. aceuticals, a division of The Harvard Drug Group,
[ Mon, Oct 29th 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Thir .. ts and Host a Conference Call to Update Investors
[ Mon, Oct 29th 2012 ] - Market Wire
IsoRay's Brain and Lung Cancer Products Showcased .. Society for Radiation Oncology (ASTRO) Convention
[ Mon, Oct 29th 2012 ] - Market Wire
NuVasive Announces Outstanding Showing at NASS 2012
[ Mon, Oct 29th 2012 ] - Market Wire
Cynapsus Therapeutics' APL 130277 for Parkinson's .. The Top Ten Neurology Projects To Watch For 2012
[ Mon, Oct 29th 2012 ] - Market Wire
ProPhase Labs Rejects Non-Binding Revised Proposa .. xx Initiatives to Be Acquired for $1.60 per Share
[ Mon, Oct 29th 2012 ] - Market Wire
Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012

Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012


Published on 2012-10-29 04:47:10 - Market Wire
  Print publication without navigation


October 29, 2012 07:30 ET

Horizon Pharma to Host an Investment Community Briefing on RAYOS® on Monday, November 12, 2012

Live Webcast to Begin at 6:30 a.m. EST

DEERFIELD, IL--(Marketwire - Oct 29, 2012) - Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) announced today that it will host a live webcast to discuss the approval and initial launch of RAYOS® on Monday, November 12, 2012 at 6:30 a.m. Eastern Time. The webcast will be hosted by Timothy P. Walbert, chairman, president and chief executive officer of Horizon Pharma and will feature presentations from leading rheumatologists Maurizio Cutolo, M.D., of the University of Genova, Frank Buttgereit, M.D., of the Charité at the University of Berlin, and Arthur Weaver, M.D., of the University of Nebraska. The live webcast and a replay may be accessed by visiting Horizon's website at [ http://ir.horizon-pharma.com ]. 

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit [ www.horizonpharma.com ].


Contributing Sources